Research / PIM

PIM kinases — TP-3654 / Nuvisertib

Genetic and pharmacologic ablation of PIM1 ameliorates myelofibrosis. UVA Cancer Center is a major site for the resulting Phase 1/2 trial (NCT04176198).

Sprint 5 — long-form essay with Scene 3 (Mol* viewer) hero and pinned-figure pattern